Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study.
暂无分享,去创建一个
Dieter Jocham | Louis Guillou | Patrice Jichlinski | Hubert van den Bergh | Per-Uno Malmström | Norbert Lange | L. Guillou | P. Malmström | D. Jocham | N. Lange | Hans-Jürg Leisinger | B. Brennhovd | Steinar J Karlsen | Bjørn Brennhovd | Eva Johansson | Thomas Gärtner | P. Jichlinski | E. Johansson | H. E. van den Bergh | H. Leisinger | S. Karlsen | Thomas Gärtner
[1] R A Risdon,et al. Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group. , 1991, British journal of urology.
[2] H. Bergh,et al. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. , 1999, The Journal of urology.
[3] J. Ferlay,et al. Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.
[4] L. Guillou,et al. Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light‐induced fluorescence of protoporphyrin IX following topical application of 5‐aminolevulinic acid: Preliminary results , 1997, Lasers in surgery and medicine.
[5] Dmitri Daniltchenko,et al. FLUORESCENCE ENDOSCOPY WITH 5-AMINOLEVULINIC ACID REDUCES EARLY RECURRENCE RATE IN SUPERFICIAL BLADDER CANCER , 2001 .
[6] M. Droller,et al. Bladder cancer: State‐of‐the‐art care , 1998, CA: a cancer journal for clinicians.
[7] H Stepp,et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.
[8] J. Rassweiler,et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. , 2002, The Journal of urology.
[9] L. Guillou,et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study , 1999, British Journal of Cancer.
[10] L. Kiemeney,et al. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group. , 1994, British journal of urology.
[11] Taylor Murray,et al. Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.
[12] H. Herr. Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients , 2005, World Journal of Urology.
[13] Thomas Filbeck,et al. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. , 2002, The Journal of urology.
[14] W. See,et al. Urothelial injury and clotting cascade activation: common denominators in particulate adherence to urothelial surfaces. , 1992, The Journal of urology.
[15] R. de Vere White,et al. Predicting prognosis in patients with superficial bladder cancer. , 1998, Oncology.
[16] K. Schomacker,et al. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5‐aminolaevulinic acid , 1999, BJU international.
[17] Joris Kloek,et al. Derivatives of 5‐Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into Protoporphyrin , 1998, Photochemistry and photobiology.